Difficulty: Medium
Average Score: 92%
Practice
A child is diagnosed with chronic constipation that has been unresponsive to dietary and activity changes. Which pharmacological measure is most appropriate?
Correct answer
C
Rationale
In pediatric patients with chronic constipation unresponsive to dietary and activity changes, the most appropriate pharmacological measure is option C) Osmotic agent (stool softener).
The rationale behind choosing an osmotic agent is that it helps to soften the stool by drawing water into the intestines, making it easier for the child to pass stools. This is particularly beneficial in cases of chronic constipation where stool hardening is a common issue. Osmotic agents are considered safe and effective for pediatric use, especially when other measures have not yielded the desired results.
Option A) Natural supplements and herbs may not provide the necessary efficacy and consistency required for managing chronic constipation in pediatric patients. Stimulant laxatives (Option B) can be harsh on the intestines and are generally not recommended for long-term use in children. Option D) stating that pharmacological measures are not used in pediatric constipation is incorrect as there are safe and effective pharmacological options available for managing chronic constipation in children under medical supervision.
Educationally, it is important to understand the pharmacological options available for managing pediatric gastrointestinal issues like chronic constipation. Knowing the appropriate use of osmotic agents in such cases can help healthcare providers make informed decisions to optimize patient care and outcomes. It is essential to consider factors like safety, efficacy, and age-appropriate dosing when selecting pharmacological interventions for pediatric patients with gastrointestinal disorders.
The rationale behind choosing an osmotic agent is that it helps to soften the stool by drawing water into the intestines, making it easier for the child to pass stools. This is particularly beneficial in cases of chronic constipation where stool hardening is a common issue. Osmotic agents are considered safe and effective for pediatric use, especially when other measures have not yielded the desired results.
Option A) Natural supplements and herbs may not provide the necessary efficacy and consistency required for managing chronic constipation in pediatric patients. Stimulant laxatives (Option B) can be harsh on the intestines and are generally not recommended for long-term use in children. Option D) stating that pharmacological measures are not used in pediatric constipation is incorrect as there are safe and effective pharmacological options available for managing chronic constipation in children under medical supervision.
Educationally, it is important to understand the pharmacological options available for managing pediatric gastrointestinal issues like chronic constipation. Knowing the appropriate use of osmotic agents in such cases can help healthcare providers make informed decisions to optimize patient care and outcomes. It is essential to consider factors like safety, efficacy, and age-appropriate dosing when selecting pharmacological interventions for pediatric patients with gastrointestinal disorders.